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The relative difference of V40, V60 and V65 between the planned value 
and the mean value of control plans were ?V40=-1% ± 16%, ?V60=-11% ± 
13%, ?V65=-31% ± 33%. 
Conclusions: The results indicate that there are variations in balloon 
position, with a tendency towards increased distance to the isocenter 
over time compared to the planning CT. This induces V65 and V60 to 
decrease whereas V40 is rather robust to the balloon shift. We could 
show that the dose to the rectal wall during treatment was the same 
or lower compared to the planned dose.  
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Purpose/Objective: Cone beam computed tomography (CBCT) 
verification images are typically obtained pre-radiotherapy for step 
and shoot intensity modulated radiotherapy (IMRT). Volumetric 
modulated arc therapy (VMAT) allows IMRT to be delivered using 
single or multiple treatment arcs and CBCT images can be acquired 
efficiently during treatment as the gantry rotates (simultaneous CBCT, 
sCBCT). These images are subject to image degradation from 
megavoltage scatter. The objective of this study is to assess feasibility 
of reliable organ delineation, and to compare organ position, on 
sCBCT as compared to CBCT in patients treated for prostate cancer. 
Materials and Methods: Five patients had standard CBCT images and 
sCBCT images taken on fractions 2, 6, 11 and 16 of radical 
radiotherapy for prostate cancer. Each sCBCT image was corrected to 
account for MV scatter and improve image quality, yielding 3 datasets 
per fraction: pre-treatment CBCT, uncorrected sCBCT (usCBCT) and 
corrected sCBCT (csCBCT). Thus 12 images per patient were available 
for analysis. Prostate, rectum and bladder volumes were delineated 
using Pinnacle v9.0 by two observers. The conformity of comparative 
volumes between each pre-delivery CBCT and corresponding usCBCT 
and csCBCT was assessed using the Dice Similarity Coefficient (DSC: 1= 
unity, 0=no overlap of volumes). Mean centroid shift (geometric 
centre of mass) was calculated to assess gross volume movement. 
Results: Results are shown in table 1. 
 
 Conclusions: Mean DSC values indicate a promising degree of 
conformity between standard CBCT and sCBCT, albeit with relatively 
large variation in centroid position. This may represent true variation 
in organ position between acquisition of CBCT and sCBCT, however 
the data set is small and inter- and intra-observer variability in 
outlining, in addition to contouring uncertainties due to poorer image 
quality of sCBCT may explain the disparity. Correction of sCBCT 
images does not appear to enhance conformity over uncorrected 
images. Outlining target and organ at risk volumes on sCBCT is 
feasible, and thus sCBCT acquired have great potential for clinical 
practice. Using current techniques, the dose to the CTV and organs at 
risk is calculated using the radiotherapy planning CT. This represents 
a single point in time and dose predictions will not be completely 
accurate due to patient and organ motion during the course of 
treatment. sCBCT allows the position of structures to be identified 
during treatment delivery thereby removing this temporal disconnect 
and positional uncertainty. Ultimately intra-fraction imaging may 
allow the dose received by structures to be calculated more 
accurately and correlated with patient outcome and toxicity, in 
addition to increasing centre throughput and efficiency. This 
technique warrants further evaluation.  
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Purpose/Objective: Hyperthermia (HT) is part of an ongoing bladder 
preservation national phase II trial using combined chemoradiotherapy 
following transurethral resection in T2-4NxM0 bladder tumours in a 
national trial. According to the protocol intravesical temperatures 
between 41.5°C to 42.5°C had to be reached for 60 minutes at the 
weekly HT sessions delivered by the deep HT unit,BSD-2000. The aim 
of this study was to evaluate quality of heating, monitor specific 
thermal parameters during the HT sessions and explore the extent of 
their variability during multiple sessions. 
Materials and Methods: Eight patients have been recruited in the 
protocol so far. A total of 43 HT sessions were delivered. Real time 
bladder temperatures were monitored using intravesical thermometry 
during 60 minutes of HT delivery. The thermal parameters evaluated 
were - minimum, maximum and average temperatures (Tmin, Tmax and 
Tav)respectively, temperature received by 20%, 50% and 90% of the 
target (T20,T50and T90) respectively, cumulative equivalent minutes of 
T90above 43°C (CEM43T90) and thermal dose (TD). 
Results: Of the 8 patients, 7 achieved a clinical complete response at 
completion of treatment. A total of 327 temperature data points were 
available for the analysis. Details of the measured values are 
summarized in the Table. Significant variability in the various thermal 
parameters was not observed, both within the individual patients and 
across the 8 patients. CEM43T90 was found to have aquadratic relation 
with Tmin, obtained by the expression, CET43T90= 5805.61 – 291.7(Tmin) 
+ 3.66(Tmin)2 (model r2=0.90,p<0.001) while TD could be derived from 
the expression, TD= -165.2 + 13.3(Tav) + 1.3(CET43T90) -9.3(T90), 
(model r2=0.89,p<0.001). 
  
Conclusions: The various thermal parameters evaluated have not 
shown significant variability during multiple HT sessions. This could be 
a consequence of effective phase and amplitude steering feasible with 
the Sigma Eye HT applicator during these HT sessions. Mathematical 
models for computation of the key parameters, namelyCEM43T90 and 
TD were derived, which in future could be used to evaluate their roles 
as potential predictors of thermotherapy. 
   
